Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Cognition Therapeutics, Inc. (CGTX) had Return on Tangible Equity of -181.18% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-33.97M |
|
-- |
|
-- |
|
$53.97M |
|
$-53.97M |
|
$20.00M |
|
$-33.97M |
|
$-33.97M |
|
$-33.97M |
|
$-33.97M |
|
$-33.97M |
|
$-33.97M |
|
$-53.97M |
|
$-53.70M |
|
39.73M |
|
39.73M |
|
$-0.86 |
|
$-0.86 |
|
| Balance Sheet Financials | |
$29.55M |
|
$0.18M |
|
$0.68M |
|
$30.23M |
|
$11.14M |
|
-- |
|
$0.34M |
|
$11.48M |
|
$18.75M |
|
$18.75M |
|
$18.75M |
|
59.85M |
|
| Cash Flow Statement Financials | |
$-28.47M |
|
$-0.00M |
|
$23.57M |
|
$29.92M |
|
$25.01M |
|
$-4.91M |
|
$3.75M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.65 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-28.48M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-181.18% |
|
|
Return on Tangible Equity |
-181.18% |
-112.36% |
|
-181.18% |
|
$0.31 |
|
$-0.72 |
|
$-0.72 |
|